Today, the U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) announced the six winners exit disclaimer icon of the $3 million KidneyX: Redesign Dialysis Phase 2 competition during the virtual KidneyX Summit exit disclaimer icon. Each recipient will receive $500,000, recognizing the transformative work and creativity these innovators have brought to reimagining dialysis care.
Redesign Dialysis Phase 2 sought prototype solutions, or components of solutions, from researchers, innovators, patients, and investors with expertise in nephrology, biotechnology, bioengineering, and medical devices to submit solutions that can replicate normal kidney functions or improve dialysis access. Prototypes addressed at least one of the following areas: blood filtration, electrolyte homeostasis, volume regulation, toxin removal and secretion, filtrate drainage and connectivity, and dialysis access… Continue reading.
Inspiration can be a hard thing to find. The history of science is filled with elusive “eureka moments” taking place under unlikely circumstances—Archimedes’ jump in a bath to intuit displacement, Issac Newton’s observation of a falling apple to grasp gravity, and Nikola Tesla’s inspiration for the electric induction motor, which came as he was observing a sunset in a park and quoting Faust. In the halls of UC San Francisco, sometimes inspiration comes knocking on the door.
Shuvo Roy, PhD, is a UCSF bioengineer working on the world’s first implantable bioartificial kidney. He also works down the hall from hundreds of people at the top of their scientific fields, in a place where scientists can make serendipitous connections just by walking out of their office doors.
That was how Roy came to partner with an embryonic stem cell expert, surgeons, fellow bioengineers, and diabetes experts, and how his work to create a bioartificial kidney spun off into something totally new—work to create a bioartificial pancreas.
“One of the amazing things about UCSF is the resources you have access to,” Roy said… Continue reading.
WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Shuvo Roy, Ph.D., Professor – Bioengineering & Therapeutic Sciences, Department of Bioengineering & Therapeutic Sciences, University of California, San Francisco (UCSF), to its College of Fellows. Dr. Roy was nominated, reviewed, and elected by peers and members of the College of Fellows For engineering an implantable artificial kidney and advancing the fields of organ replacement and biosensor technology using micro and nanotechnology..